The explosion of awareness around cannabidiol (CBD) products is difficult to ignore. Storefronts in strip malls boast a variety of related products and considerable financial backing has fueled many startup companies.
A recent article in Green Entrepreneur reboots the sleep side of the CBD equation, touting CDC estimates that one in three adults in the U.S. does not get enough sleep—a familiar statistic that came before the coronavirus pandemic.
“A group of researchers from Colorado published study results in 2019 that showed CBD positively impacted those who lost sleep due to anxiety,” writes a Green Entrepreneur reporter. “Of those involved in the study, 79.2 percent saw anxiety levels fall within the first month of using CBD for sleep. Also, 66.7 percent experienced an improvement in their sleep in the first month, although this number fluctuated over the ensuing months.
No less than Harvard Medical School reported: CBD is commonly used to address anxiety, and for patients who suffer through the misery of insomnia, studies suggest that CBD may help with both falling asleep and staying asleep. CBD may offer an option for treating different types of chronic pain. A study from the European Journal of Pain showed, using an animal model, CBD applied on the skin could help lower pain and inflammation due to arthritis.
On a more sober note, Harvard’s Peter Grinspoon, M.D. concludes by remarking: “Without sufficient high-quality evidence in human studies we can’t pinpoint effective doses, and because CBD is currently is mostly available as an unregulated supplement, it’s difficult to know exactly what you are getting.”